WBAD Stock Overview
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 3/6 |
Past Performance | 0/6 |
Financial Health | 1/6 |
Dividends | 2/6 |
Walgreens Boots Alliance, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$6.10 |
52 Week High | US$12.50 |
52 Week Low | US$6.00 |
Beta | 0.75 |
1 Month Change | -19.42% |
3 Month Change | -28.66% |
1 Year Change | -51.20% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -64.74% |
Recent News & Updates
Recent updates
Shareholder Returns
WBAD | AR Consumer Retailing | AR Market | |
---|---|---|---|
7D | -3.9% | -3.7% | -7.0% |
1Y | -51.2% | -3.9% | 302.7% |
Return vs Industry: WBAD underperformed the AR Consumer Retailing industry which returned -4.1% over the past year.
Return vs Market: WBAD underperformed the AR Market which returned 303.2% over the past year.
Price Volatility
WBAD volatility | |
---|---|
WBAD Average Weekly Movement | 10.3% |
Consumer Retailing Industry Average Movement | 4.8% |
Market Average Movement | 9.5% |
10% most volatile stocks in AR Market | 14.4% |
10% least volatile stocks in AR Market | 7.3% |
Stable Share Price: WBAD's share price has been volatile over the past 3 months.
Volatility Over Time: WBAD's weekly volatility (10%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1909 | 268,500 | Tim Wentworth | www.walgreensbootsalliance.com |
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S.
Walgreens Boots Alliance, Inc. Fundamentals Summary
WBAD fundamental statistics | |
---|---|
Market cap | US$15.18b |
Earnings (TTM) | -US$6.04b |
Revenue (TTM) | US$144.60b |
0.1x
P/S Ratio-2.5x
P/E RatioIs WBAD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
WBAD income statement (TTM) | |
---|---|
Revenue | US$144.60b |
Cost of Revenue | US$117.72b |
Gross Profit | US$26.88b |
Other Expenses | US$32.91b |
Earnings | -US$6.04b |
Last Reported Earnings
Feb 29, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -7.00 |
Gross Margin | 18.59% |
Net Profit Margin | -4.18% |
Debt/Equity Ratio | 61.7% |
How did WBAD perform over the long term?
See historical performance and comparison